TFPI-2 is frequently downregulated in the vast majority of aggressive tumors such as glioma [311], breast cancer [312], melanoma [313], colorectal cancer [314], and pancreatic cancer [315], just to name a few. This evidence concerns the gene TFPI2 and breast cancer.